Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally

JA Dykens, CE Peterson, HK Holt… - Frontiers in Public …, 2023 - frontiersin.org
Human papillomavirus (HPV) infection is responsible for many cancers in both women and
men. Cervical cancer, caused by HPV, is the fourth most common cancer among women …

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

K Canfell, JJ Kim, M Brisson, A Keane, KT Simms… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

A framework for cervical cancer elimination in low-and-middle-income countries: a scoping review and roadmap for interventions and research priorities

MB Shin, G Liu, N Mugo, PJ Garcia, DW Rao… - Frontiers in public …, 2021 - frontiersin.org
The World Health Organization announced an ambitious call for cervical cancer elimination
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …

Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial

AR Kreimer, JN Sampson, C Porras… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The authors investigated the durability of vaccine efficacy (VE) against human
papillomavirus (HPV) 16 or 18 infections and antibody response among nonrandomly …

Human papillomavirus vaccination after COVID-19

ZQ Toh, FM Russell, SM Garland… - JNCI Cancer …, 2021 - academic.oup.com
The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to
derail the uptake of human papillomavirus (HPV) vaccination in low-and lower-middle …

Global elimination of cervical cancer as a public health problem

M Brisson, M Drolet - The Lancet Oncology, 2019 - thelancet.com
Adam Gault/Science Photo Library achieving elimination is possible, and to understand the
potential effects of different screening and human papillomavirus (HPV) vaccination …

[HTML][HTML] Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination

S Joshi, D Anantharaman, R Muwonge, N Bhatla… - Vaccine, 2023 - Elsevier
Abstract Background The recent World Health Organization recommendation supporting
single-dose of HPV vaccine will significantly reduce programmatic cost, mitigate the supply …

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study

I Man, D Georges, TM de Carvalho… - The Lancet …, 2022 - thelancet.com
Background Despite the high burden of cervical cancer, access to preventive measures
remains low in India. A single-dose immunisation schedule could facilitate the scale-up of …

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

C Porras, SH Tsang, R Herrero, D Guillén… - The Lancet …, 2020 - thelancet.com
Background Oncogenic human papillomavirus (HPV) infections cause most cases of
cervical cancer. Here, we report long-term follow-up results for the Costa Rica Vaccine Trial …